Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Saunders, CN, Cornish, AJ, Kinnersley, B, Law, PJ, Claus, EB, Il'yasova, D, Schildkraut, J, Barnholtz-Sloan, JS, Olson, SH, Bernstein, JL, Lai, RK, Chanock, S, Rajaraman, P, Johansen, C, Jenkins, RB, Melin, BS, Wrensch, MR, Sanson, M, Bondy, ML & Houlston, RS 2020, 'Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis', Neuro-Oncology, bind 22, nr. 2, s. 207-215. https://doi.org/10.1093/neuonc/noz209

APA

Saunders, C. N., Cornish, A. J., Kinnersley, B., Law, P. J., Claus, E. B., Il'yasova, D., Schildkraut, J., Barnholtz-Sloan, J. S., Olson, S. H., Bernstein, J. L., Lai, R. K., Chanock, S., Rajaraman, P., Johansen, C., Jenkins, R. B., Melin, B. S., Wrensch, M. R., Sanson, M., Bondy, M. L., & Houlston, R. S. (2020). Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis. Neuro-Oncology, 22(2), 207-215. https://doi.org/10.1093/neuonc/noz209

CBE

Saunders CN, Cornish AJ, Kinnersley B, Law PJ, Claus EB, Il'yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS. 2020. Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis. Neuro-Oncology. 22(2):207-215. https://doi.org/10.1093/neuonc/noz209

MLA

Vancouver

Saunders CN, Cornish AJ, Kinnersley B, Law PJ, Claus EB, Il'yasova D o.a. Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis. Neuro-Oncology. 2020 feb 20;22(2):207-215. https://doi.org/10.1093/neuonc/noz209

Author

Saunders, Charlie N ; Cornish, Alex J ; Kinnersley, Ben ; Law, Philip J ; Claus, Elizabeth B ; Il'yasova, Dora ; Schildkraut, Joellen ; Barnholtz-Sloan, Jill S ; Olson, Sara H ; Bernstein, Jonine L ; Lai, Rose K ; Chanock, Stephen ; Rajaraman, Preetha ; Johansen, Christoffer ; Jenkins, Robert B ; Melin, Beatrice S ; Wrensch, Margaret R ; Sanson, Marc ; Bondy, Melissa L ; Houlston, Richard S. / Lack of association between modifiable exposures and glioma risk : a Mendelian randomization analysis. I: Neuro-Oncology. 2020 ; Bind 22, Nr. 2. s. 207-215.

Bibtex

@article{d2c4cdf64b524590acb1ae39ccd33960,
title = "Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis",
abstract = "BACKGROUND: The etiological basis of glioma is poorly understood. We have used genetic markers in a Mendelian randomization (MR) framework to examine if lifestyle, cardiometabolic, and inflammatory factors influence the risk of glioma. This methodology reduces bias from confounding and is not affected by reverse causation.METHODS: We identified genetic instruments for 37 potentially modifiable risk factors and evaluated their association with glioma risk using data from a genome-wide association study of 12 488 glioma patients and 18 169 controls. We used the estimated odds ratio of glioma associated with each of the genetically defined traits to infer evidence for a causal relationship with the following exposures:Lifestyle and dietary factors-height, plasma insulin-like growth factor 1, blood carnitine, blood methionine, blood selenium, blood zinc, circulating adiponectin, circulating carotenoids, iron status, serum calcium, vitamins (A1, B12, B6, E, and 25-hydroxyvitamin D), fatty acid levels (monounsaturated, omega-3, and omega-6) and circulating fetuin-A;Cardiometabolic factors-birth weight, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, total triglycerides, basal metabolic rate, body fat percentage, body mass index, fasting glucose, fasting proinsulin, glycated hemoglobin levels, diastolic and systolic blood pressure, waist circumference, waist-to-hip ratio; andInflammatory factors- C-reactive protein, plasma interleukin-6 receptor subunit alpha and serum immunoglobulin E.RESULTS: After correction for the testing of multiple potential risk factors and excluding associations driven by one single nucleotide polymorphism, no significant association with glioma risk was observed (ie, PCorrected > 0.05).CONCLUSIONS: This study did not provide evidence supporting any of the 37 factors examined as having a significant influence on glioma risk.",
keywords = "Brain Neoplasms, Diet/adverse effects, Glioma, Humans, Inflammation/complications, Life Style, Mendelian Randomization Analysis, Metabolism/genetics, Risk Factors",
author = "Saunders, {Charlie N} and Cornish, {Alex J} and Ben Kinnersley and Law, {Philip J} and Claus, {Elizabeth B} and Dora Il'yasova and Joellen Schildkraut and Barnholtz-Sloan, {Jill S} and Olson, {Sara H} and Bernstein, {Jonine L} and Lai, {Rose K} and Stephen Chanock and Preetha Rajaraman and Christoffer Johansen and Jenkins, {Robert B} and Melin, {Beatrice S} and Wrensch, {Margaret R} and Marc Sanson and Bondy, {Melissa L} and Houlston, {Richard S}",
note = "{\textcopyright} The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.",
year = "2020",
month = feb,
day = "20",
doi = "10.1093/neuonc/noz209",
language = "English",
volume = "22",
pages = "207--215",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Lack of association between modifiable exposures and glioma risk

T2 - a Mendelian randomization analysis

AU - Saunders, Charlie N

AU - Cornish, Alex J

AU - Kinnersley, Ben

AU - Law, Philip J

AU - Claus, Elizabeth B

AU - Il'yasova, Dora

AU - Schildkraut, Joellen

AU - Barnholtz-Sloan, Jill S

AU - Olson, Sara H

AU - Bernstein, Jonine L

AU - Lai, Rose K

AU - Chanock, Stephen

AU - Rajaraman, Preetha

AU - Johansen, Christoffer

AU - Jenkins, Robert B

AU - Melin, Beatrice S

AU - Wrensch, Margaret R

AU - Sanson, Marc

AU - Bondy, Melissa L

AU - Houlston, Richard S

N1 - © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.

PY - 2020/2/20

Y1 - 2020/2/20

N2 - BACKGROUND: The etiological basis of glioma is poorly understood. We have used genetic markers in a Mendelian randomization (MR) framework to examine if lifestyle, cardiometabolic, and inflammatory factors influence the risk of glioma. This methodology reduces bias from confounding and is not affected by reverse causation.METHODS: We identified genetic instruments for 37 potentially modifiable risk factors and evaluated their association with glioma risk using data from a genome-wide association study of 12 488 glioma patients and 18 169 controls. We used the estimated odds ratio of glioma associated with each of the genetically defined traits to infer evidence for a causal relationship with the following exposures:Lifestyle and dietary factors-height, plasma insulin-like growth factor 1, blood carnitine, blood methionine, blood selenium, blood zinc, circulating adiponectin, circulating carotenoids, iron status, serum calcium, vitamins (A1, B12, B6, E, and 25-hydroxyvitamin D), fatty acid levels (monounsaturated, omega-3, and omega-6) and circulating fetuin-A;Cardiometabolic factors-birth weight, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, total triglycerides, basal metabolic rate, body fat percentage, body mass index, fasting glucose, fasting proinsulin, glycated hemoglobin levels, diastolic and systolic blood pressure, waist circumference, waist-to-hip ratio; andInflammatory factors- C-reactive protein, plasma interleukin-6 receptor subunit alpha and serum immunoglobulin E.RESULTS: After correction for the testing of multiple potential risk factors and excluding associations driven by one single nucleotide polymorphism, no significant association with glioma risk was observed (ie, PCorrected > 0.05).CONCLUSIONS: This study did not provide evidence supporting any of the 37 factors examined as having a significant influence on glioma risk.

AB - BACKGROUND: The etiological basis of glioma is poorly understood. We have used genetic markers in a Mendelian randomization (MR) framework to examine if lifestyle, cardiometabolic, and inflammatory factors influence the risk of glioma. This methodology reduces bias from confounding and is not affected by reverse causation.METHODS: We identified genetic instruments for 37 potentially modifiable risk factors and evaluated their association with glioma risk using data from a genome-wide association study of 12 488 glioma patients and 18 169 controls. We used the estimated odds ratio of glioma associated with each of the genetically defined traits to infer evidence for a causal relationship with the following exposures:Lifestyle and dietary factors-height, plasma insulin-like growth factor 1, blood carnitine, blood methionine, blood selenium, blood zinc, circulating adiponectin, circulating carotenoids, iron status, serum calcium, vitamins (A1, B12, B6, E, and 25-hydroxyvitamin D), fatty acid levels (monounsaturated, omega-3, and omega-6) and circulating fetuin-A;Cardiometabolic factors-birth weight, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, total triglycerides, basal metabolic rate, body fat percentage, body mass index, fasting glucose, fasting proinsulin, glycated hemoglobin levels, diastolic and systolic blood pressure, waist circumference, waist-to-hip ratio; andInflammatory factors- C-reactive protein, plasma interleukin-6 receptor subunit alpha and serum immunoglobulin E.RESULTS: After correction for the testing of multiple potential risk factors and excluding associations driven by one single nucleotide polymorphism, no significant association with glioma risk was observed (ie, PCorrected > 0.05).CONCLUSIONS: This study did not provide evidence supporting any of the 37 factors examined as having a significant influence on glioma risk.

KW - Brain Neoplasms

KW - Diet/adverse effects

KW - Glioma

KW - Humans

KW - Inflammation/complications

KW - Life Style

KW - Mendelian Randomization Analysis

KW - Metabolism/genetics

KW - Risk Factors

U2 - 10.1093/neuonc/noz209

DO - 10.1093/neuonc/noz209

M3 - Journal article

C2 - 31665421

VL - 22

SP - 207

EP - 215

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 2

ER -

ID: 64232325